Comparison between different first-line therapy protocols in eradicating Helicobacter pylori in a region with high clarithromycin resistance

Yilmaz B., Koseoglu H., Coskun Y., Deveci M., Kekilli M.

GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, vol.13, no.2, pp.150-156, 2018 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 13 Issue: 2
  • Publication Date: 2018
  • Doi Number: 10.5114/pg.2018.72732
  • Journal Name: GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
  • Page Numbers: pp.150-156
  • Keywords: Helicobacter pylori eradication, clarithromycin resistance, STANDARD TRIPLE THERAPY, SEQUENTIAL THERAPY, ANTIBIOTIC-RESISTANCE, QUADRUPLE THERAPY, INFECTION, BISMUTH, MANAGEMENT, EFFICACY, TRIAL, AMOXICILLIN
  • Gazi University Affiliated: No

Abstract

Introduction: Helicobacter pylori infection is encountered in more than 50% of the world population. A high rate of clarithromycin resistance is observed among Helicobacter pylori strains in some regions because clarithromycin is a drug commonly used for the treatment of other infections.